VOYA INVESTMENT MANAGEMENT LLC - KYTHERA BIOPHARMACEUTICALS I ownership

Quarter-by-quarter ownership
VOYA INVESTMENT MANAGEMENT LLC ownership history of KYTHERA BIOPHARMACEUTICALS I
ValueSharesWeighting
Q3 2015$829,000
-10.2%
11,058
-9.8%
0.00%0.0%
Q2 2015$923,000
+78.5%
12,254
+18.8%
0.00%
+100.0%
Q1 2015$517,000
+44.4%
10,3130.0%0.00%0.0%
Q4 2014$358,000
+5.9%
10,3130.0%0.00%0.0%
Q3 2014$338,000
-14.6%
10,3130.0%0.00%0.0%
Q2 2014$396,000
+17.5%
10,313
+21.5%
0.00%0.0%
Q1 2014$337,000
+6.6%
8,4860.0%0.00%0.0%
Q4 2013$316,000
-18.6%
8,4860.0%0.00%0.0%
Q3 2013$388,000
+68.7%
8,4860.0%0.00%0.0%
Q2 2013$230,0008,4860.00%
Other shareholders
KYTHERA BIOPHARMACEUTICALS I shareholders Q4 2015
NameSharesValueWeighting ↓
Palo Alto Investors LP 1,810,518$71,986,0002.98%
Redmile Group, LLC 443,326$17,627,0002.10%
AlpInvest Partners B.V. 22,224$884,0002.04%
SENZAR ASSET MANAGEMENT, LLC 89,500$3,558,0001.88%
Aureus Asset Management, LLC 136,305$5,419,0001.39%
PFM Health Sciences, LP 1,003,492$39,899,0000.72%
REGENTATLANTIC CAPITAL LLC 176,454$7,016,0000.68%
Ghost Tree Capital, LLC 25,000$994,0000.59%
HAMILTON LANE ADVISORS LLC 30,264$1,203,0000.48%
Pentwater Capital Management LP 390,000$15,506,0000.41%
View complete list of KYTHERA BIOPHARMACEUTICALS I shareholders